Peijia’s DCwire Guidewire Gains FDA Clearance
Published: 24 Mar 2026
Author: Precedence Research
On March 18, 2026, Peijia Medical Limited, a prominent manufacturer of minimally invasive surgical devices, has moved one step forward in its global expansion journey with the FDA 510(k) clearance of its DCwire Micro Guidewire. The DCwire Micro Guidewire is engineered to facilitate smooth navigation through complex vascular pathways, thereby becoming an essential tool in various complex procedures such as neurovascular and cardiovascular procedures. This type of guidewire is a vital accessory that helps surgeons accurately reach target tissues and vessels where ligation clips, vessel sealing instruments, and other tissue closure devices are utilized.
First U.S Approval Signals Global Ambition
This FDA clearance also highlights the strategic focus of the company on the global market. The DCwire Micro Guidewire features a microstructured design that offers flexibility in navigating through anatomical structures. This product has already shown success in the Chinese market, with good adoption in endovascular procedures that require precision. The clearance also highlights the research and development strength of the company, in addition to the opportunities that exist for integrating the product with ligation and vessel closure devices.
The global ligation device market size was calculated at USD 1.84 billion in 2025 and is predicted to increase from USD 1.97 billion in 2026 to approximately USD 3.71 billion by 2035, expanding at a CAGR of 7.26% from 2026 to 2035 as the demand grows for minimally invasive surgical procedures, endoscopic procedures and quick and safe vascular and gastrointestinal surgical procedures.
Impact on Ligation Device Market
The accurate navigation of the guidewire through anatomical spaces is necessary for the safe and precise use of ligation clips, bands and energy-based systems that are deployed in minimally invasive procedures. Analysts suggest that these supporting devices play an important role in the larger surgical landscape, as hospitals and surgical centers adopt the latest technologies in minimally invasive surgeries.
Peijia’s achievement is a significant milestone in the company’s global growth journey. The company is capitalizing on innovation in navigating tools and the growing need for minimally invasive procedures. This enhances the overall ecosystem that drives the use of ligation devices, hinting at future opportunities in this sector.
A recent report by Precedence Research highlights that the ligation device market is benefiting from the advances in biocompatible materials, an increase in the number of surgical procedures, and the focus of the healthcare industry on reducing the duration of surgical procedures and recovery times.